Nephros, Inc.
NEPHNASDAQHealthcareMedical Instruments & Supplies
As of Oct 16, 2026 close
- Market cap
- $39.01M
- P/E (TTM)
- 22.47
- Forward P/E
- 17.16
- Dividend yield
- -
- 52-week range
- $2.66$6.42
- Volume (live)
- -
- Avg. volume (3M)
- 34.47K
Nephros (NEPH) Stock Price & Financial Analysis
Nephros Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $3.39 - $3.65 |
|---|---|
| 52-Week High | $6.42 |
| 52-Week Low | $2.66 |
| Open | $3.45 |
| Volume (last close) | 46.00K |
| Average Volume (3M) | 34.47K |
| Revenue (TTM) | 20.72M |
|---|---|
| Net Income (TTM) | 1.74M |
| Free Cash Flow (TTM) | -661.00K |
| EPS (TTM) | $0.16 |
| Profit Margin | 8.38% |
| Operating Margin | 7.92% |
| Return on Equity (ROE) | 14.51% |
| Debt to Equity | 0.07 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Market Cap | 39.01M |
|---|---|
| Shares Outstanding | 11.11M |
| P/E Ratio (TTM) | 22.47 |
| Forward P/E | 17.16 |
| Price to Sales (P/S) | 1.88 |
| Price to Book (P/B) | 3.26 |
| EV/EBITDA | 18.72 |
| 50-Day MA | $4.10 |
|---|---|
| 200-Day MA | $3.75 |
| 1-Year Change | −28.22% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Nephros at a Glance
As of the Oct 16, 2026 close, Nephros (NEPH) has a market capitalization of $39.01M. The stock trades at 22.5× trailing earnings, 17.2× forward earnings and 1.9× sales. Over the trailing twelve months it earned $1.74M on revenue of $20.72M (a 8.4% profit margin) and burned $661.00K of free cash flow. Revenue grew 24.2% year over year.
As of its latest reported balance sheet, it holds $4.70M in cash and securities against $872.00K of debt, a net cash position of $3.83M.
Nephros does not currently pay a dividend.
The share price is down 28.2% over the past year. At $3.65 (the Oct 16, 2026 close) it sits within its 52-week range of $2.66 to $6.42, below its 200-day moving average of $3.75.
Frequently Asked Questions About Nephros
What is the current stock price for NEPH?
As of the Oct 16, 2026 close, NEPH stock trades at $3.65. The 52-week range is $2.66–$6.42, with a day range of $3.39–$3.65.
What is the P/E ratio for NEPH?
As of the Oct 16, 2026 close, Nephros's trailing twelve-month (TTM) P/E ratio is 22.5, meaning investors pay $22.5 for every $1 of annual earnings. The forward P/E is 17.2, reflecting analyst expectations for future earnings. Nephros operates in the Healthcare sector.
Does NEPH pay dividends?
Nephros does not currently pay a regular dividend. The company retains its earnings to reinvest in the business. Check the Dividends tab for historical dividend information.
What do analysts recommend for NEPH?
Analyst ratings and recommendations for NEPH are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of NEPH?
As of the Oct 16, 2026 close, Nephros's market capitalization is $40.6M, classifying it as a micro-cap company. Nephros operates in the Healthcare sector within the Medical Instruments & Supplies industry.